Ken-Tye Yong Selected Research

Quantum Dots (Quantum Dot)

1/2019	Biodegradable Polymer-Coated Multifunctional Graphene Quantum Dots for Light-Triggered Synergetic Therapy of Pancreatic Cancer.
1/2017	Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells.
12/2015	Cytotoxicity assessment of functionalized CdSe, CdTe and InP quantum dots in two human cancer cell models.
1/2015	Assembling Mn:ZnSe quantum dots-siRNA nanoplexes for gene silencing in tumor cells.
1/2015	Passive tumor targeting and imaging by using mercaptosuccinic acid-coated near-infrared quantum dots.
11/2013	Theranostic quantum dots for crossing blood-brain barrier in vitro and providing therapy of HIV-associated encephalopathy.
1/2012	Bioconjugated pluronic triblock-copolymer micelle-encapsulated quantum dots for targeted imaging of cancer: in vitro and in vivo studies.
7/2011	WITHDRAWN: Synthesis and Characterization of Anticancer Drug and Antibody conjugated Quantum Dots as A Novel Theranostic Probe for Pancreatic Cancer Detection and Therapy.
6/2011	Bioconjugation of luminescent silicon quantum dots for selective uptake by cancer cells.
4/2011	Non-invasive tumor detection in small animals using novel functional Pluronic nanomicelles conjugated with anti-mesothelin antibody.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ken-Tye Yong Research Topics

Disease

55	Neoplasms (Cancer) 01/2022 - 03/2007
28	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 06/2007
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 08/2015
3	Adenocarcinoma 01/2018 - 12/2008
3	Infections 01/2017 - 04/2012
3	Substance-Related Disorders (Drug Abuse) 04/2012 - 04/2009
2	Liver Neoplasms (Liver Cancer) 11/2020 - 10/2017
2	Neoplasm Metastasis (Metastasis) 09/2015 - 02/2015
2	Brain Diseases (Brain Disorder) 11/2013 - 04/2009
2	Squamous Cell Carcinoma of Head and Neck 06/2013 - 02/2012
2	Neuroinflammatory Diseases 01/2012 - 07/2009
1	Nasopharyngeal Carcinoma 01/2021
1	COVID-19 11/2020
1	Hyperemia 01/2020
1	Spontaneous Abortion (Miscarriage) 01/2019
1	Carcinoma (Carcinomatosis) 10/2017
1	Central Nervous System Neoplasms 01/2017
1	Human Influenza (Influenza) 01/2017
1	Philadelphia Chromosome 04/2016
1	Leukemia 04/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2016
1	AIDS Dementia Complex 02/2015
1	Glaucoma 02/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2012
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2012

Drug/Important Bio-Agent (IBA)

17	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2009
15	Pharmaceutical PreparationsIBA 09/2019 - 09/2010
11	GoldIBA 11/2020 - 01/2009
8	MicellesIBA 01/2019 - 05/2008
5	Folic Acid (Vitamin M)FDA LinkGeneric 11/2020 - 01/2012
5	Peptides (Polypeptides)IBA 04/2016 - 03/2009
5	Biological ProductsIBA 04/2016 - 01/2009
5	LigandsIBA 01/2015 - 06/2007
4	PolyestersIBA 01/2019 - 03/2015
4	PolymersIBA 01/2019 - 07/2014
4	CadmiumIBA 01/2019 - 03/2009
4	IntegrinsIBA 04/2016 - 03/2009
4	Contrast MediaIBA 01/2013 - 06/2007
4	cyclic arginine-glycine-aspartic acid peptideIBA 10/2010 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2008
3	Interleukin-8 (Interleukin 8)IBA 01/2019 - 07/2014
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 02/2011
3	SiliconIBA 06/2011 - 05/2008
3	Transferrin (beta 2 Transferrin)IBA 07/2010 - 03/2007
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2019 - 10/2017
2	Coloring Agents (Dyes)IBA 08/2015 - 08/2010
2	PolyelectrolytesIBA 01/2015 - 07/2010
2	Galectin 1 (LGALS1)IBA 09/2012 - 04/2012
2	Poloxamer (Poloxamer 407)IBA 01/2012 - 04/2011
2	Arginine (L-Arginine)FDA Link 04/2011 - 03/2011
2	MesothelinIBA 04/2011 - 12/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2010 - 03/2009
2	Monoclonal AntibodiesIBA 03/2009 - 06/2007
1	Carbon DioxideIBA 09/2021
1	Hyaluronic Acid (Hyaluronan)IBA 11/2020
1	dextran-bound sulfonamideIBA 11/2020
1	SARS-CoV-2 spike proteinIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 10/2019
1	GraphiteIBA 01/2019
1	2-(dimethylamino)ethyl methacrylateIBA 01/2019
1	polycaprolactoneIBA 01/2019
1	Ribonuclease H (RNase H)IBA 10/2017
1	Cytochromes c (Cytochrome c)IBA 10/2017
1	oxophenylarsine (phenylarsine oxide)IBA 10/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2017
1	graphene oxideIBA 01/2017
1	phytochlorinIBA 10/2016
1	bcr-abl Fusion ProteinsIBA 04/2016
1	arginyl-glycyl-aspartic acidIBA 04/2016
1	ormosilIBA 08/2015
1	Silicon Dioxide (Silica)FDA LinkGeneric 08/2015
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2015
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 02/2015
1	2-thiomalic acidIBA 01/2015
1	Carbon Nanotubes (Carbon Nanotube)IBA 09/2014
1	ChemokinesIBA 07/2014
1	poly(lactide) (polylactic acid)IBA 08/2013
1	NanocapsulesIBA 08/2013
1	Methamphetamine (Desoxyn)FDA LinkGeneric 09/2012
1	Morphine (MS Contin)FDA LinkGeneric 04/2012
1	sphingosine kinaseIBA 02/2012
1	OccludinIBA 01/2012

Therapy/Procedure

26	Therapeutics 09/2021 - 12/2008
23	Quantum Dots (Quantum Dot) 01/2019 - 06/2007
5	Precision Medicine 01/2019 - 04/2010
4	Drug Therapy (Chemotherapy) 09/2019 - 08/2013
3	Intravenous Injections 01/2015 - 04/2011
2	Micro-Electrical-Mechanical Systems 02/2015 - 08/2013
2	Nanospheres 06/2013 - 01/2011
1	RNAi Therapeutics 09/2021
1	Aftercare (After-Treatment) 09/2021
1	Phototherapy (Light Therapy) 01/2018
1	Photothermal Therapy 10/2017
1	Induced Hyperthermia (Thermotherapy) 01/2017
1	Photochemotherapy (Photodynamic Therapy) 10/2016
1	Electrodes (Electrode) 01/2014
1	Lab-On-A-Chip Devices 01/2014
1	Radiotherapy 02/2012